Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 682-131-9 | CAS number: 1190427-50-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test substance was tested for skin sensitisation according to OECD TG 429 and under GLP. This study identified a potential for dermal sensitization and resulted in obligatory labelling requirement for skin sensitisation and classification into Category 1.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Study was carried out or initiated before 11 October 2016 and addresses the standard information requirement. In vitro testing was therefore not considered.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- July 22, 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo (formed partially from Harlan in September 2015), 5800 AN Venray, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: SPF, animals were derived from a controlled full-barrier maintained breeding system
- Age at study initiation: 8–9 weeks
- Weight at study initiation: 19-22 g
- Housing: full barrier in an air-conditioned room, animals were kept in groups of 5 animals in IVC cages, type II L, polysulphone cages on Altromin saw fibre bedding
- Diet (e.g. ad libitum): ad libitum, Altromin 1324 maintenance diet for rats and mice
- Water (e.g. ad libitum): ad libitum, sulphur acidified to a pH value of approx. 2.8 (drinking water, municipal residue control, microbiological controls at regular intervals)
- Acclimation period: at least five days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 55 ± 10%
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12 hours light, 12 hours dark - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 6.25%, 12.5% and 25% (w/v)
- No. of animals per dose:
- 5 mice / dose group and 10 mice / prescreen test
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: the maximum technically applicable concentration of the test item in the vehicle was found to amount 25% in AOO
- Irritation: signs of excessive irritation were not detected in any animal treated with either 25 or 12.5% at any application site
- Systemic toxicity: signs of systemic toxicity were not detected in any animal treated with either 25 or 12.5%
- Ear thickness measurements: ear thickness measurements were performed on day 1 (pre-dose), day 3 (approximately 48 hours after the first dose) and day 6
- Erythema scores: both ears were observed for erythema and scored according to Table 1 of the attached file
Excessive local irritation was indicated by an erythema score ≥ 3 and/or ear swelling of ≥ 25% and absent in this test
. Please see attached file for detailed data of the prescreen test
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response:
The proliferative response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (DPM/NODE) and as the ratio of 3H-methyl thymidine - incorporation into lymph node cells of test group animals relative to that recorded for control group animals (STIMULATION INDEX). Before DPM/NODE values were determined, background values were subtracted.
EC3 values, calculated concentrations which induce stimulation indices of three, were determined by linear interpolation, EC3=c+[(3-d)/(b-d)]x(a-c), between two points of the stimulation indices axis, one above (a,b) and one below (c,d) the stimulation index of three. If all measured points were above or below the stimulation index of three, no EC3 value could be stated.
A substance was regarded as a 'sensitiser' in the LLNA if at least one concentration of the test item resulted in a 3-fold or greater increase in 3H-methyl thymidine - incorporation into lymph node cells of the test group animals, relative to that recorded for the lymph nodes of control group animals (Stimulation Index equal to or greater than 3.0).
TREATMENT PREPARATION AND ADMINISTRATION:
3 test groups (3 different concentrations), 1 positive control group (1% phenylene-diamine in AOO) and 1 negative-control group (vehicle) were tested.
Topical Application:
Each mouse was treated by topical application of 25 μL of the selected solution to the entire dorsal surface of each ear.
Topical applications were performed once daily over three consecutive days. The first treatment day was defined as study day 1.
Administration of 3H-Methyl Thymidine:
Five days after the first topical application, all mice were dosed with 20 μCi 3H-methyl thymidine by intravenous injection (tail vein) of 250 μl of 3H-methyl thymidine, diluted with PBS to a working concentration of 80 μCi/ml.
Preparation of Cell Suspension:
Approximately 5 hours after the injection of 3H-methyl thymidine, all mice were sacrificed by cervical dislocation. The draining auricular lymph nodes were excised, individually pooled for each animal (2 lymph nodes per animal) and collected in phosphate buffered saline (PBS). A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through polyamide gauze (200 mesh size). After washing the gauze with PBS the cell suspension was pelleted in a centrifuge. The supernatant was discarded and the pellets were resuspended with PBS. This washing procedure was repeated.
After the final wash, each pellet was resuspended in approx. 1 ml 5% TCA at approx. 4° C for approximately 18 hours for precipitation of macromolecules. Each precipitate was once washed again, resuspended in 1 ml 5% TCA and 7 ml scintillation fluid was added. Then this solution was transferred into scintillation vials and stored at room temperature overnight.
Determination of Incorporated 3H -Methyl Thymidine:
The 3H-methyl thymidine – incorporation was measured in a ß-counter and expressed as the number of disintegrations per minute (DPM). Similarly, background 3H-methyl thymidine levels were also measured (5% TCA). Determination of radioactivity was performed individually for each animal. - Positive control substance(s):
- other: phenylenediamine
- Positive control results:
- The stimulation index of the positive control (1% phenylenediamine in AOO) was 5.6 and therefore the test was considered to be valid.
- Key result
- Parameter:
- SI
- Value:
- 3.2
- Test group / Remarks:
- 25%
- Key result
- Parameter:
- SI
- Value:
- 4.2
- Test group / Remarks:
- 12.5%
- Key result
- Parameter:
- SI
- Value:
- 4.7
- Test group / Remarks:
- 6.25%
- Key result
- Parameter:
- EC3
- Remarks on result:
- not determinable
- Remarks:
- inverse dose-response relationship
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA and DETAILS ON STIMULATION INDEX CALCULATION
The proliferative response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (DPM/NODE) and as the ratio of 3H-methyl thymidine - incorporation into lymph node cells of test group animals relative to that recorded for control group animals (STIMULATION INDEX). Before DPM/NODE values were determined, background values were subtracted.
EC3 CALCULATION
EC3 values, calculated concentrations which induce stimulation indices of three, were determined by linear interpolation, EC3=c+[(3-d)/(b-d)]x(a-c), between two points of the stimulation indices axis, one above (a,b) and one below (c,d) the stimulation index of three. If all measured points were above or below the stimulation index of three, no EC3 value could be stated.
CLINICAL OBSERVATIONS:
Prior to the application and once a day thereafter all animals were observed in order to detect signs of toxicity, including dermal irritation at site of application.
BODY WEIGHTS
The animals were weighed prior to the application and at the end of the test period (prior to the treatment with 3HTdR).
Please see attached file for results. - Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- Each of the tested concentrations exceeded the stimulation index of 3. The EC3 value could not be calculated due to an inverse a dose-response relationship of the data obtained.
Consequently, the test item is considered to be a dermal sensitiser. According to Commission Regulation (EU) No 286/2011 as well as GHS (Globally Harmonized Classification System), the test item has obligatory labelling requirement for skin sensitisation and is classified into Category 1. - Executive summary:
A valid test for skin sensitisation according to OECD Guideline and under GLP was carried out with the test substance and identified the substance as a skin sensitiser of GHS Category 1.
Reference
Please see attached file for results.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Each of the tested concentrations exceeded the stimulation index of 3. Consequently, according to OECD TG 429, the test item is considered to be a dermal sensitiser.
The EC3 value could not be calculated due to an inverse dose-response relationship of the data obtained. According to Commission Regulation (EU) No 286/2011 as well as GHS (Globally Harmonized Classification System), the test item has obligatory labelling requirement for skin sensitisation and is classified into Category 1.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.